PerkinElmer Announces Financial Results for the First Quarter of 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Oppenheimer sees AI software winners as focus shifts to ROI
- Arm Holdings falls as CFO stock sale weighs on sentiment
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
PerkinElmer (PKI) Tops Q1 EPS by 65c, Offers Guidance
May 4, 2021 5:00 PM EDTPerkinElmer (NYSE: PKI) reported Q1 EPS of $3.72, $0.65 better than the analyst estimate of $3.07. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.21 billion.
GUIDANCE:
PerkinElmer sees Q2 2021 EPS of $2.35, versus the consensus of $2.35. PerkinElmer sees Q2 2021 revenue... More
